Navigation Links
Arena Pharmaceuticals Announces First Quarter 2009 Financial Results
Date:5/11/2009

mon stock to Azimuth at a pre-negotiated discount to the market price.

  • Received net proceeds of $14.6 million as reimbursement for improvements made to one of Arena's facilities.

  • Announced the completion of a positive randomized, double-blind, placebo-controlled Phase 1 program and the initiation of a Phase 2 clinical trial of a second generation oral niacin receptor agonist intended for the treatment of atherosclerosis in Arena's partnership with Merck.

Scheduled Earnings Call

Arena will host both a conference call and webcast to discuss the first quarter 2009 financial results and to provide a business and financial update today, Monday, May 11, 2009, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Jack Lief, President and Chief Executive Officer and Robert E. Hoffman, Vice President, Finance and Chief Financial Officer will host the conference call.

The conference call may be accessed by dialing 877.857.6151 for domestic callers and 719.325.4806 for international callers. Please specify to the operator that you would like to join the "Arena Pharmaceuticals First Quarter 2009 Earnings Call." The conference call will be webcast live under the investor relations section of Arena's website at www.arenapharm.com, and will be archived there for 30 days following the call. Please connect to Arena's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

Upcoming Corporate Presentations

Arena is planning to present at upcoming investment and industry conferences, including:

  • The 34th Annual Deutsche Bank Health Care Confer
    '/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Monday, May 11, 2009
2. Arena Pharmaceuticals Obtains Equity Financing Commitment of Up to $50 Million
3. Arena Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference
4. Arena Pharmaceuticals to Present at the Oppenheimer 19th Annual Healthcare Conference
5. Arena Pharmaceuticals to Report Third Quarter 2008 Financial Results and to Host Conference Call and Webcast on Thursday, October 30, 2008
6. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
7. Arena Pharmaceuticals to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
9. Arena Pharmaceuticals Announces Second Quarter 2008 Financial Results and Recent and Second Quarter Highlights
10. Arena Pharmaceuticals to Report Second Quarter 2008 Financial Results and to Host Conference Call and Webcast on Tuesday, August 5, 2008
11. Arena Pharmaceuticals to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...GTON, Colo., Nov. 5 The endangered... the western U.S. This rare carnivore feeds on pr...e to plague and often entire population die-offs i...ce (FWS) has implemented a ferret breeding program...nto their formerly native habitat. Unfortunately,...
(Date:11/5/2009)... Neb., Nov. 5 Transgenom...d financial results for the quarter ended Septembe...esented in the tables that follow. ,, Third Qu...of $366,000 or $0.01 per share for the third quart...r $0.01 per share for the third quarter of 2008. ...
(Date:11/5/2009)...T, Calif., Nov. 5 WaferG...leading developer of state-of-the-art genetic anal...rs, Ph.D. has joined the company,s Scientific Advi...ing and commercializing novel molecular diagnostic... on the development of computational biology syste...
(Date:11/5/2009)... Brooke Sanders brings a new look to ...RWEB) November 5, 2009 -- Professional Reprographi...phics company is pleased to present Brooke Sanders... graphics/PR specialist. The addition of Brooke to...rowth within Professional Reprographics., , ,Brook...
Breaking Biology Technology:Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4
...ept. 10 /Xinhua-PRNewswire-FirstCall/ -- China Sky...anufacturer, marketer and,distributor of pharmaceu...today announced that it won the bidding process or...hnology for a $1.5 million grant to further,develo...t. These six,products were created by First Bio-En...
....J., Sept. 10 Millennium,Biotechnologies Group, I...aised $2,277,000 through the private placement of ...een registered under the Securities Act of 1933,an...absent registration,under such Act or an applicabl...llennium, through its wholly owned subsidiary, Mil...
... 10 ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ) a...y,focused on commercializing proprietary product c...us diseases, announced today that it has received,...ation (FDA) regarding its,proposed 505(b)(2) New D...(docetaxel emulsion). The FDA has indicated that d...
Other Biology Technology:China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products 2China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products 3Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Completion of $2,277,000 Equity Financing 2ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA 2ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA 3ADVENTRX Announces ANX-514 Clinical Development Plan Affirmed by the FDA 4
(Date:11/4/2009)...ntists at the University of North Carolina at Chap...alifornia, San Francisco have developed and experi...diseases for existing drugs. , The researchers d...similar the structures of all known drugs are to t...s ligands -- of disease targets within the cell. I...
(Date:11/3/2009)...he ultimate loner of the ocean, cruising thousands...chers has discovered that the sharks have maintain...r tens of thousands of years the white sharks in t...elves into a population genetically distinct from ...re a large, highly mobile species," said Salvador ...
(Date:11/3/2009)...A Henry Samueli School of Engineering and Applied ...stituted in the laboratory the enzyme responsible ... drug lovastatin. , The research, published O... lead to the development of other compounds with s...-synthesizing enzyme is one of the most interestin...
Breaking Biology News(10 mins):Study points to new uses, unexpected side effects of already existing drugs 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin 2ESHRE launches international study of polar body screening 9030 1ESHRE launches international study of polar body screening 9030 2New trigger for chronic inflammation in rheumatoid arthritis discovered 9028 1New trigger for chronic inflammation in rheumatoid arthritis discovered 9028 2Constipation May Lead to Other Problems 50223 1Constipation May Lead to Other Problems 50223 2Constipation May Lead to Other Problems 50223 3
...tunning discovery based on epigenetics (the inheri...s that consuming cholinea nutrient found in eggs a...ffect breast cancer outcomes for a mother,s offspr...n University is the first to link choline consumpt...the first to identify possible choline-related gen...
...vaux and Gow demonstrate how a tight junction prot...eath a snug fit. The study will be published in th...iology ( www.jcb.org ). , Like the rubber coatin...tension of glial cells that spirals around the axo...ents current leakage from axons and aids electrica...
...ients who have had the common chest wall deformity...ed body image and ability to exercise, according t...trics . , The study, conducted at 11 North Americ...e than 200 patients between the ages of 8 and 21 w...rviewed parents as well. , The results were drama...
Other Biology News:Eating eggs when pregnant affects breast cancer in offspring 2Marked improvement in body image, physical stamina, post-surgical pectus patients report 2Marked improvement in body image, physical stamina, post-surgical pectus patients report 3
Mouse Anti-Human ACP2 Monoclonal Antibody, Unconjugated, Clone M1-4A12 from Novus Biologicals
...rocking platform, 120 V, is used for agitation and...of liquid cultures, staining and destaining of gel...r features variable speed control (8-40 rpm) and c...cker features two 29 x 21 cm platforms covered wit...
... of enzymes involved in matrix degradation. Of the...y ten exist in soluble form whereas MT-MMPs exist ...T3-MMP also known as MMP14, MMP15, MMP16 respectiv...oring them to the cell surface. They have an 8 ami...
...no- bis (3-ethylbenzthiazoline-6-sulfonic Acid) ...al concentrations of ABTS and H 2 O 2 in a citrat...roxidase substrate that is soluble, safe, convenie... ™ develops intense blue-green color that c...
Biology Products: